abstract |
The present invention is directed to novel 2-(quinolonyl)-fused heterocyclyl derivatives of the general formula (I) n n n wherein R 1 , R 2 , R 3 , R 3a , R 4 , R 5 , R 6 and R 7 are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor. |